The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
11.99
+0.93 (8.41%)
At close: May 12, 2025, 4:00 PM
12.01
+0.02 (0.17%)
After-hours: May 12, 2025, 4:18 PM EDT
The Chemours Company Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for The Chemours Company stock have an average target of 18.78, with a low estimate of 14 and a high estimate of 27. The average target predicts an increase of 56.63% from the current stock price of 11.99.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for The Chemours Company stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 5 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $15 | Hold | Maintains | $22 → $15 | +25.10% | May 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $14 | Buy | Maintains | $17 → $14 | +16.76% | May 8, 2025 |
| UBS | UBS | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +41.78% | May 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $27 → $22 | Strong Buy | Maintains | $27 → $22 | +83.49% | Apr 14, 2025 |
| Barclays | Barclays | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | +33.44% | Apr 1, 2025 |
Financial Forecast
Revenue This Year
6.09B
from 5.78B
Increased by 5.27%
Revenue Next Year
6.30B
from 6.09B
Increased by 3.45%
EPS This Year
1.89
from 0.57
Increased by 232.08%
EPS Next Year
2.70
from 1.89
Increased by 42.62%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.3B | 6.6B | 6.9B |
| Avg | 6.1B | 6.3B | 6.6B |
| Low | 5.7B | 5.5B | 6.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.3% | 8.3% | 9.5% |
| Avg | 5.3% | 3.4% | 5.0% |
| Low | -1.3% | -10.0% | -4.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.43 | 3.53 | 3.68 |
| Avg | 1.89 | 2.70 | 3.21 |
| Low | 1.44 | 2.11 | 2.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 325.5% | 86.4% | 36.1% |
| Avg | 232.1% | 42.6% | 18.8% |
| Low | 152.2% | 11.3% | -3.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.